back to team members

Kevin Hrusovsky

Executive Chairman of the Board

Kevin Hrusovsky is an American biotech entrepreneur, engineer, and healthcare visionary who has dedicated his 30-year career to transforming medicine from reactive “sick care” to preventative and personalized healthcare.

Hrusovsky is leading the charge to establish a new paradigm for healthy living based on peer-reviewed science that addresses the continuum from health to disease at the molecular structure level in the human body. He catalyzed a precision health movement that began in 2008 with the launch of the Revolutionaries for Global Health Summit Series to promote innovation for eradicating disease and personalizing global health. In 2016, Hrusovsky founded Powering Precision Health, the annual summit that quickly become the industry’s leading platform and premier forum for advancing the deep science that powers precision health.

An acclaimed life sciences and healthcare authority, Hrusovsky is regularly asked to provide both in-depth analysis and the big picture view on achieving industry-wide transformation to true precision medicine. He has been a featured guest on numerous media outlets, including ABC’s Good Morning America, CBS, NBC, CNN, CNBC, NPR Science Friday, USA Today, Forbes, Fortune, Bloomberg, Wall Street Journal, New York Times, International Business Times, Washington Post, STAT, Quartz, HuffPost, The Guardian, Scientific American, Boston Globe, Wired, and Fast Company.

Hrusovsky has been recognized with many awards and accolades, including a 2017 BBJ Innovation All-Star award for transforming the practices of medicine and health. He is a three-time Award Finalist of the EY Entrepreneur of the Year® (2007, 2017 and 2018) and received the Lifetime Achievement Award for Leadership (2018) and E.G. Bailey Entrepreneurship Award (2013), both from The Ohio State University. In 2015, Hrusovsky was named a BostInno’s 50 on Fire Awards Finalist in Healthcare and Medicine.

A coveted thought leader and dynamic speaker, Hrusovsky is regularly invited to keynote and participate at leading conferences, executive summits and panel discussions, including the BIO International Convention, J.P. Morgan Healthcare Conference, One Mind Summit, Konkussion Retreat, PULSE: The Atlantic Summit on Health Care, MedCity CONVERGE, Next Generation Dx Summit, the annual conference of the Personalized Medicine Coalition, and World Innovation Forum.

He currently serves as Executive Chairman of the Board of Quanterix, a company digitizing biomarker analysis to advance the science of precision health. In 2017, he took Quanterix public in one of the most successful IPOs for a life science tools company in recent history. Under his leadership, the company acquired Aushon and regained all rights and privileges associated with its groundbreaking Simoa technology through the termination of a license agreement with bioMérieux.

Prior to joining Quanterix, he was President of Life Sciences and Technologies at PerkinElmer, CEO of Caliper Life Sciences (now PerkinElmer), and CEO of Zymark Corporation (now PerkinElmer). Previously, he served as President of FMC Corporation’s Pharmaceuticals and head of International Agricultural Products and held key management positions at E.I. DuPont de Nemours.

Hrusovsky is renowned for his strong track record of launching disruptive technologies, building fast-growing companies, and developing successful commercialization strategies. He lends his business expertise on the boards of innovative technology companies including BioreclamationIVT, Caliper Life Sciences, Cell Signaling Technology, 908 Devices, Cellaria, SeraCare, Synap Dx, Xenogen and Solect Energy. Hrusovsky is committed to education and serves on the Educational Board of the Massachusetts Biotech Council, the Advisory Committee for the Center for Biomedical Engineering at Brown University, the Association for Laboratory Automation, the JALA Editorial Board, and the Strategy Committee of Children’s Hospital Boston.

Hrusovsky holds an M.B.A. from Ohio University and a B.S. in Mechanical Engineering from The Ohio State University. He received an Honorary Doctorate from Framingham State University for his vast contributions in life sciences and personal medicine. In addition, he helped build competitive strategy curriculum at the Institute for Strategy & Competitiveness at Harvard Business School. Follow Kevin Hrusovsky on Twitter @KevinHrusovsky and LinkedIn @KevinHrusovsky.